Table 2.
Univariate and multivariate analysis of overall survival predicted by FASTKD2.
| Category | Total number of people (n) | Single factor analysis | Multivariate analysis | |||
|---|---|---|---|---|---|---|
| Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | |||
| FASTKD2 | 503 | |||||
| High expression | 251 | Reference | ||||
| Low expression | 252 | 0.696 (0.519-0.935) | 0.016 | 0.810 (0.592-1.107) | 0.186 | |
| GENDER | 503 | |||||
| Male | 235 | Reference | ||||
| female sex | 268 | 0.938 (0.700-1.256) | 0.666 | |||
| AJCC staging | 503 | |||||
| Phase I | 280 | Reference | ||||
| Phase II | 118 | 2.114 (1.466-3.049) | <0.001 | 1.003 (0.542-1.854) | 0.993 | |
| Phase III | 79 | 3.268 (2.245-4.756) | <0.001 | 1.545 (0.629-3.795) | 0.343 | |
| Stage IV | 26 | 3.461 (2.005-5.974) | <0.001 | 6.516 (0.600-70.729) | 0.123 | |
| M | 503 | |||||
| M0 | 336 | Reference | ||||
| M1 | 25 | 2.021 (1.181-3.457) | 0.010 | 0.291 (0.027-3.115) | 0.308 | |
| MX | 142 | 0.809 (0.565-1.160) | 0.250 | 0.906 (0.624-1.314) | 0.602 | |
| N | 503 | |||||
| N3 | 14 | Reference | ||||
| N0 | 330 | 0.856 (0.314-2.334) | 0.761 | 1.394 (0.429-4.535) | 0.581 | |
| N1 | 90 | 1.965 (0.709-5.449) | 0.194 | 2.906 (0.843-10.017) | 0.091 | |
| N2 | 69 | 2.555 (0.913-7.155) | 0.074 | 2.501 (0.674-9.287) | 0.171 | |
| T | 503 | |||||
| T1 | 170 | Reference | ||||
| T2 | 266 | 1.553 (1.087-2.218) | 0.015 | 1.260 (0.868-1.828) | 0.224 | |
| T3 | 49 | 2.862 (1.713-4.784) | <0.001 | 2.289 (1.230-4.258) | 0.009 | |
| T4 | 18 | 3.242 (1.706-6.158) | <0.001 | 1.517 (0.709-3.244) | 0.283 | |
| Smoking | 503 | |||||
| yes | 421 | Reference | ||||
| no | 82 | 1.082 (0.745-1.572) | 0.679 | |||
| Age | 503 | |||||
| >65 | 256 | Reference | ||||
| ≤65 | 247 | 0.841 (0.628-1.128) | 0.248 | |||